Société Syndax Pharmaceuticals, Inc.
Actions
SNDX
US87164F1057
Recherche biotechnologique et médicale
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
20,48 USD | -1,32 % | -2,29 % | -5,41 % |
Métier
Nombre d'employés: 184
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 05/05/15 |
Peter Ordentlich
FOU | Founder | 55 | 11/10/05 |
Neil Gallagher
PSD | President | 60 | 10/04/23 |
Keith Goldan
DFI | Director of Finance/CFO | 52 | 13/06/22 |
Chief Tech/Sci/R&D Officer | 52 | - | |
Sharon P. Klahre
IRC | Investor Relations Contact | - | 13/06/22 |
Anjali Ganguli
PRN | Corporate Officer/Principal | 48 | 01/05/15 |
Kevin McManus
HRO | Human Resources Officer | - | 01/05/23 |
Luke Albrecht
LAW | General Counsel | 45 | 01/08/16 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 29/03/17 |
Dennis Podlesak
CHM | Chairman | 66 | 01/12/08 |
Pierre Legault
BRD | Director/Board Member | 63 | 04/01/17 |
William Meury
BRD | Director/Board Member | 56 | 25/09/18 |
Martin Huber
BRD | Director/Board Member | 64 | 15/09/21 |
Michael Metzger
CEO | Chief Executive Officer | 53 | 05/05/15 |
Jennifer Jarrett
BRD | Director/Board Member | 53 | 25/09/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 84 987 060 | 83 418 403 ( 98,15 %) | 0 | 98,15 % |
Coordonnées société
Syndax Pharmaceuticals, Inc.
35 Gatehouse Drive Building D
02451, Waltham
+781 419 1400
http://www.syndax.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-5,41 % | 1,76 Md | |
+62,95 % | 62,59 Md | |
-2,46 % | 41,18 Md | |
+44,53 % | 40,29 Md | |
-8,29 % | 27,9 Md | |
+12,56 % | 26,21 Md | |
-21,78 % | 19,09 Md | |
+5,19 % | 13,08 Md | |
+24,68 % | 12,26 Md | |
+28,19 % | 12,05 Md |
- Bourse
- Actions
- Action SNDX
- Société Syndax Pharmaceuticals, Inc.